Electroporation as an efficient physical enhancer for skin drug delivery

Journal of Clinical Pharmacology

Volumn 49, Issue 11, 2009, Pages 1262-1283

  Escobar Chávez, José Juan ^a   Bonilla Martínez, Dalia ^a   Villegas Gonzélez, Martha Angélica ^a   Revilla Vázquez, Alma Luisa ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Electroporation; Physical enhancers; Skin; Transdermal drug delivery

Indexed keywords

ANTIDIURETIC AGENT; ATENOLOL; CYCLODEXTRIN; DEXTRAN; FLUOROURACIL; FOLIC ACID ANTAGONIST; INSULIN; PHOTOSENSITIZING AGENT; PIROXICAM; TERAZOSIN; TIMOLOL;

DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG TRANSPORT; ELECTROCHEMOTHERAPY; ELECTROOSMOSIS; EPIDERMIS; GENE TRANSFER; HUMAN; IONTOPHORESIS; REVIEW; SKIN PERMEABILITY; STRATUM CORNEUM; TRANSDERMAL PATCH; WOUND HEALING;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIDIURETIC AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CATECHIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTRANS; DRUG DELIVERY SYSTEMS; ELECTROPORATION; FOLIC ACID ANTAGONISTS; GENE TRANSFER TECHNIQUES; HORMONES; HUMANS; INSULIN; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES; PHOTOSENSITIZING AGENTS; SKIN; WOUND HEALING;

EID: 70350393807     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009344984     Document Type: Review

References (114)

1. Elias PM Epidermal lipids, barrier function and desquamation. J Invest Dermatol. 1983 ; 80: 44-49.
2. Cleary GW Transdermal delivery systems: a medical rationale. In: Shah VP, Maibach HI, eds. Topical Drug Bioavailability, Bioequivalence and Penetration. New York: Plenum; 1993 :17.
3. Scheuplein RJ, Blank IH Permeability of the skin. Physiol Rev. 1971 ; 51: 702-747.
4. Williams AC, Barry BW Penetration enhancers. Adv Drug Deliv Rev. 2004 ; 56: 603-618.
5. Pellet M., Raghavan SL, Hadgraft J., Davis AF The application of supersaturated systems to percutaneous drug delivery. In: Guy RH, Hadgraft J, eds. Transdermal Drug Delivery. New York: Marcel Dekker ; 2003: 305.
6. Tsai JC, Guy RH, Thornfeldt CR, et al. Metabolic approaches to enhance transdermal drug delivery: 1. Effect of lipid synthesis inhibitors. J Pharm Sci. 1998 ; 85: 643-648.
7. Elias PM, Feingold KR, Tsai J., Thornfeldt C., Menon G. Metabolic approach to transdermal drug delivery. In: Guy RH, Hadgraft J, eds. Transdermal Drug Delivery. New York: Marcel Dekker ; 2003: 285.
8. Schreier H., Bouwstra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release. 1994 ; 30: 1-15.
9. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst. 1996 ; 13: 257-388.
10. Cevc G. Transferosomes: innovative transdermal drug carriers. In: Rathbone MJ, Hadgraft J, Roberts MS, eds. Modified Release Drug Delivery Technology. New York: Marcel Dekker ; 2003: 533.
11. Godin B., Touitou E. Ethosomes: new prospects in transdermal delivery. Crit Rev Ther Drug Carrier Syst. 2003 ; 20: 63-102.
12. Brown MB, Traynor MJ, Martin GP, Akomeah FK Transdermal drug delivery systems: skin perturbation devices. In: Jain KK, ed. Drug Delivery Systems. Vol. 37. Totowa, NJ: Humana ; 2008: 119-139.
13. Escobar-Chvez JJ, Merino-Sanjun V., L?3pez-Cervantes M., et al. The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation. Curr Drug Discov Technol. 2009 Sep 1. [Epub ahead of print]
14. Merino V., Mic-Albiana T., Ncher A., Dez-Sales O., Herrez M., Merino-Sanjun M. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis. J Pharm Pharmacol. 2008 ; 60: 415-420.
15. El-Kamel AH, Al-Fagih IM, Alsarra IA Effect of sonophoresis and chemical enhancers on testosterone transdermal delivery from solid lipid microparticles: an in vitro study. Curr Drug Deliv. 2008 ; 5: 20-26.
16. Zhang L., Widera G., Rabussay D. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant. Bioelectrochemistry. 2004 ; 63: 369-373.
17. Banga AK, Bose S., Ghosh TK Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999 ; 179: 1-19.
18. Prausnitz MR A practical assessment of transdermal drug delivery by skin electroporation. Adv Drug Deliv Rev. 1999 ; 35: 61-76.
19. Vanbever R., Prat V. In vivo efficacy and safety of skin electroporation. Adv Drug Deliv Rev. 1999 ; 35: 77-88.
20. Forslind BA Domain mosaic model of skin barrier. Acta Derm Venereol. 1994 ; 74: 1-6.
21. Potts RO, Francoeur ML The influence of stratum corneum morphology on water permeability. J Invest Dermatol. 1991 ; 96: 495-499.
22. Potts RO, Guy RH Predicting skin permeability. Pharm Res. 1992 ; 9: 663-669.
23. Ellias PM Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism. J Control Release. 1991 ; 15: 199-208.
24. Barry BW Dermatological formulations: percutaneous absorption. In: Swarbick J, ed. Drugs and the Pharmaceutical Sciences. New York: Marcel Dekker ; 1983: 202.
25. Hadgraft J. Skin, the final frontier. Int J Pharm. 2001 ; 224 (1-2). 1-18.
26. Guy RH, Hadgraft J. Transdermal Drug Delivery. New York: Marcel Dekker ; 2003.
27. Walters KA, Roberts MS Dermatological and Transdermal Formulations. New York: Marcel Dekker ; 2002.
28. Nevill AM The need to scale for differences in body size and mass: and explanation of Klieberĝs 0.75 mass exponent. Am Physiol Soc. 1994 ; 77: 2870-2873.
29. Olvera-Martnez BI, Cazares-Delgadillo J., Calderilla-Fajardo SB, Villalobos-Garca R., Ganem-Quintanar A., Quintanar-Guerrero D. Preparation of polymeric nanocapsules containing octyl methoxycinnamate by the emulsification-diffusion technique: penetration across the stratum corneum. J Pharm Sci. 2005 ; 94: 1552-1559.
30. Escobar-Chvez JJ, Quintanar-Guerrero D., Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in PF-127 gels: Effect of Azone?« and Transcutol?«. Drug Develop Ind Pharm. 2005 ; 31: 447-454.
31. Escobar-Chvez JJ, L?3pez-Cervantes M., Nak A., Kalia YN, Quintanar-Guerrero D., Ganem-Quintanar A. Applications of the thermoreversible Pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharmaceut Sci. 2006 ; 9: 339-358.
32. Miyazaki S., Yokouchi Ch, Nakamura T., Hashiguchi N., Hou W-M., Takada M. Pluronic F-127 gels as a novel vehicle for rectal administration of indomethacin. Chem Pharm Bull. 1986 ; 34: 1801-1808.
33. Chi S. -Ch, Do K., Tan HK, Chun HW Anti-inflammatory and analgesic transdermal gel. US patent number 5, 527, 832, 1996.
34. Fang JY, Leu YL, Wang YY, Tsai YH In vitro topical application and in vivo pharmacodynamic evaluation of nonivamide hydrogels using Wistar rat as an animal model. Eur J Pharm Sci. 2002 ; 15: 417-423.
35. Shin SC, Cho CW, Oh IJ Effects of non ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. Int J Pharm. 2001 ; 222: 199-203.
36. Liaw J., Lin Y. -Ch. Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl. J Control Release. 2000 ; 68: 273-282.
37. Wang YY, Hong CT, Chiu WT, Fang JY In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm. 2001 ; 224: 1-2.
38. Kattan El AF, Asbill CS, Kim N., Michniak BB Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations. Drug Deliv. 2000 ; 7 (3). 147-153.
39. Curdy C., Kalia YN, Nak A., Guy RH Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. J Control Release. 2001 ; 76: 73-79.
40. Mattorano DA, Kupper LL, Nylander-French LA Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg. 2004 ; 48: 139-146.
41. Chao Y. -Ch, Nylander-French LA Determination of keratin protein in a tape-stripped skin sample from jet fuel exposed skin. Ann Occup Hyg. 2004 ; 48: 65-73.
42. Chizmadzhev YA, Zamitsin VG, Weaver JC, Potts UO Mechanism of electroinduced ionic species transport through a multilamellar lipid system. Biophysical J. 1995 ; 68: 749-765.
43. Chizmadzhev YA, Indenbom AV, Kuzmin PI, Galichenko SV, Weaver JC, Potts RO Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J. 1998 ; 74: 843-856.
44. Jiali B., Hong W., Huiping W., Jiguang G. Quantitative description and model of molecule transport through skin. Presented at: 26th Annual International Conference of the IEEE EMBS ; September 1-5, 2004 ; San Francisco, California.
45. Treco DA, Selden RF Non-viral gene therapy. Mol Med Today. 1995 ; 1: 314-321.
46. Weaver JC Electroporation theory: concepts and mechanisms. In: Nickoloff JA, ed. Electroporation Protocols for Microorganisms. Totowa, NJ: Humana; 1995 :1.
47. Prausnitz, MR, Bose VG, Langer R., Weaver JC Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA. 1993 ; 90: 10504-10508.
48. Inada H., Ghanem AH, Higuchi WI Studies on the effects of applied voltage and duration on human epidermal membrane alteration: recovery and the resultant effects upon iontophoresis. Pharm Res. 1994 ; 11: 687-697.
49. Weaver JC, Chizmadzhev Y. Electroporation. In: Polte C, Postow E, eds. Biological Effects of Electromagnetic Fields. Boca Raton, FL: CRC Press ; 1996: 247.
50. Edwards DA, Prausnitz MR, Langer R., Weaver JC Analysis of enhanced transdermal transport by skin electroporation. J Control Release. 1995 ; 34: 211-221.
51. Prausnitz MR Do high-voltage pulses cause changes in skin structure ? J Control Release. 1996 ; 40: 321-326.
52. Vanbever R., Lecouturier N., Preat V. Transdermal delivery of metoprolol by electroporation. Pharm Res. 1994 ; 11: 1657-1662.
53. Vanbever R., LeBoulenge E., Preat V. Transdermal delivery of fentanyl by electroporation: 1. Influence of electrical factors. Pharm Res. 1996 ; 13: 559-565. (Pubitemid 26119058)
54. Choi MJ, Maibach HI Topical vaccination of DNA antigens: topical delivery of DNA antigens. Skin Pharmacol Appl Skin Physiol. 2003 ; 16: 271-282.
55. Wang S., Kara M., Krishnan TR Topical delivery of cyclosporin A coevaporate using electroporation technique. Drug Dev Ind Pharm. 1997 ; 23: 657-663.
56. Prausnitz MR, Edelman ER, Gimm JA, Langer R., Weaver JC Transdermal delivery of heparin by skin electroporation. Biotechnology. 1995 ; 13: 1205-1209.
57. Zewert TE, Pliquett UF, Langer R., Weaver JC Transdermal transport of DNA antisense oligonucleotides by electroporation. Biochem Biophys Res Commun. 1995 ; 212: 286-292.
58. Brand RM, Wahl A., Iverson PL Effects of size and sequence on the iontophoretic delivery of oligonucleotides. J Pharm Sci. 1998 ; 87: 49-52.
59. Zhang L., Hofmann GA Electric pulse mediated transdermal drug delivery. Proc Int Symp Control Release Bioact Mater. 1997 ; 24: 27-28.
60. Pliquett U., Gallo S., Hui SW, Gusbeth C., Neumann E. Local and transient structural changes in stratum corneum at high electric fields: contribution of Joule heating. Bioelectrochemistry. 2005 ; 67: 37-46.
61. Fang JY, Huang Y. -B, Wang H. -Y, Tsai Y. -H. Electrically-assisted skin permeation of two synthetic capsaicin derivatives, sodium nonivamide acetate and sodium nonivamide propionate, via rate-controlling polyethylene membranes. Biol Pharm Bull. 2005 ; 28: 1695-1701.
62. Murthy SN, Sen A., Zhao YL, Hui SW pH influences the post-pulse permeability state of skin after electroporation. J Control Release. 2003 ; 93: 49-57.
63. Hu Q., Liang W., Bao J., Ping Q. Enhanced transdermal delivery of tetracaine by electroporation. Int J Pharm. 2000 ; 202: 121-124.
64. Bommannan DB, Tamada J., Leung L., Potts RO Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm Res. 1994 ; 11: 1809-1814.
65. Murthy SN, Zhao Y., Hui SW, Sen A. Synergistic effect of anionic lipid enhancer and electroosmosis for transcutaneous delivery of insulin. Int J Pharm. 2006 ; 326 (1 / 2). 1-6.
66. Regnier V., Prat V. Mechanisms of a phosphorothioate oligonucleotide delivery by skin electroporation. Int J Pharm. 1999 ; 184: 147-156.
67. Vanbever R., Leroy MA, Prat V. Transdermal permeation of neutral molecules by electroporation. J Control Release. 1998 ; 54: 243-250.
68. Li LH, McCarthy P., Hui SW High-efficiency electrotransfection of human primary hematopoietic stem cells. FASEB J. 2001 ; 15: 586-588.
69. Yew NS, Zhao H., Przybylska M., et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther. 2002 ; 5: 731-738.
70. Chen S., Shohet RV, Bekeredjian R., Frenkel P., Grayburn PA Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol. 2003 ; 42: 301-308.
71. Ding Z., Fach C., Sasse A., Godecke A., Schrader J. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Ther. 2004 ; 11: 260-265.
72. Tanaka S., Iwai M., Harada Y., et al. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter. Cancer Gene Ther. 2000 ; 7: 1241-1250.
73. Keravala A., Groth AC, Jarrahian S., et al. A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Mol Genet Genomics. 2006 ; 276: 135-146.
74. Nickoloff JA Preface. In: Nickoloff JA, ed. Electroporation Protocols for Microorganisms. Totowa, NJ: Humana; 1995 :5.
75. Miller EM, Nickoloff JA Escherichia coli electrotransformation. In: Nickoloff JA, ed. Electroporation Protocols for Microorganisms. Totowa, NJ: Humana ; 1995: 105.
76. Tetsuichiro S. In Vivo Electroporation. http://www.frontier.kyoto-u.ac. jp/rc01/in-vivo-electroporation.html. Accessed February 15, 2003.
77. Weaver JC Electroporation theory: concepts and mechanisms. In: Nickoloff JA, ed. Electroporation Protocols for Microorganisms. Totowa, NJ: Humana; 1995 :1.
78. Pliquett U., Langer R., Weaver JC Changes in the electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta. 1995 ; 1239: 111-121.
79. Mir L., Orlowski S., Belehradek JJ, Paolelli C. Electrochemotherapy: potentiation of antitumor effect of bleomycin by electric pulses. Eur J Cancer. 1991 ; 27: 68-72.
80. Heller R., Jaroszeski R., Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumor using electrochemotherapy. Cancer. 1996 ; 77: 964-971.
81. Murthy SN, Zhao Y. -L, Sen A., Hui SW Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. J Control Release. 2004 ; 99: 393-402.
82. Huang JF, Sung KC, Hu O Y-P, Wang JJ, Lin YH, Fang JY The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm. 2005 ; 297: 162-171.
83. Sung KC, Fang J. -Y, Wang JJ, Hu O Y-P. Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci. 2003 ; 18: 63-70.
84. Fang J-Y., Hwang T-L., Huang Y-B., Tsai Y-H. Transdermal iontophoresis of sodium nonivamide acetate: V. Combined effect of physical enhancement methods. Int J Pharm. 2002 ; 235: 95-105.
85. Vanbever R., Prausnitz MR, Prat V. Macromolecules as novel transdermal transport enhancers for skin electroporation. Pharm Res. 1997 ; 14: 638-644.
86. Badkar AV, Smith AM, Eppstein JA, Banga AK Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm Res. 2007 ; 24: 1389-1395.
87. Sharma A., Kara M., Smith FR, Krishnan TR Transdermal drug delivery using electroporation: II. Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats. J Pharm Sci. 2000 ; 89: 536-544. (Pubitemid 30690343)
88. Sharma A., Kara M., Smith FR, Krishnan TR Transdermal drug delivery using electroporation: I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats. J Pharm Sci. 2000 ; 89: 528-535. (Pubitemid 30690342)
89. Denet A. -N, Ucakar B., Prat V. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach. Pharm Res. 2003 ; 20: 1946-1951.
90. Fang J. - Y. Hung Ch-F, Fang Y. -P, Chan T. -F. Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm. 2004 ; 270: 241-249.
91. Sersa G., Miklavcic D., Cemazar M., Rudolf Z., Pucihar G., Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol. 2008 ; 34: 232-240.
92. Murthy SN, Zhao Y. -L, Marlan K., Hui SW, Kazim AL, Sen A. Lipid and electroosmosis enhanced transdermal delivery of insulin by electroporation. J Pharm Sci. 2006 ; 95: 2041-2050. (Pubitemid 44433033)
93. Tokumoto S., Higo N., Sugibayashi K. Effect of electroporation and pH on the iontophoretic transdermal delivery of human insulin. Int J Pharm. 2006 ; 326: 13-19.
94. Medi BM, Singh J. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). Int J Pharm. 2003 ; 263: 25-33.
95. Chang S. -L, Hofmann GA, Zhang L., Deftos LJ, Banga AK The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones. J Control Release. 2000 ; 66: 127-133.
96. Essa EA, Bonner MC, Barry BW Electrically assisted skin delivery of liposomal estradiol: phospholipid as damage retardant. J Control Release. 2004 ; 95: 535-546.
97. Johnson PG, Hui SW, Oseroff AR Electrically enhanced percutaneous delivery of d-aminolevulinic acid using electric pulses and a DC potential. Photochem Photobiol. 2002 ; 75: 534-540.
98. Fang JY, Lee W. -R, Shen S. -C, Fang Y. -P, Hu C-H. Dermatological surgery and lasers enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol. 2004 ; 151: 132-140.
99. Regnier V., Tahiri A., Andr N., Lemaitrec M., Prat V. Electroporation-mediated delivery of 3ĝ€2-protected phosphodiester oligodeoxynucleotides to the skin. J Control Release. 2000 ; 67: 337-346.
100. Zhao YL, Murthy SN, Manjili MH, Guana LJ, Sena A., Hui SW Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization. Vaccine. 2006 ; 24: 1282-1290.
101. Hui SW The application of electroporation to transfect hematopoietic cells and to deliver drugs and vaccines transcutaneously for cancer treatment. Technol Cancer Res Treat. 2002 ; 1: 373-384.
102. Fang JY, Hung CF, Hwang TL, Wong WW Transdermal delivery of tea catechins by electrically assisted methods. Skin Pharmacol Physiol. 2006 ; 19: 28-37.
103. Marrat F., Levy JL, Santi P., Kalia YN In vitro evaluation of electrotreatment on skin permeability. J Cosmet Dermatol. 2008 ; 7: 105-111.
104. Sen A., Zhao Y., Zhang L., Hui SW Enhanced transdermal transport by electroporation using anionic lipids. J Control Release. 2002 ; 82: 399-405. (Pubitemid 34880193)
105. Tokudome Y., Sugibayashi K. Mechanism of the synergic effects of calcium chloride and electroporation on the in vitro enhanced skin permeation of drugs. J Control Release. 2004 ; 95: 267-274.
106. Murthy SN, Sen A., Hui SW Surfactant-enhanced transdermal delivery by electroporation. J Control Release. 2004 ; 98: 307-315. 107. Wong T-W., Zhao Y-L., Sen A., Hui SW Pilot study of topical delivery of methotrexate by electroporation. Br J Dermatol. 2005 ; 152: 524-530.
107. Wong TW, Chen Ch-H, Huang Ch-Ch, Lin Ch-D, Hui SW Painless electroporation with a new needle-free microelectrode array to enhance transdermal drug delivery. J Control Release. 2006 ; 110: 557-565.
108. Heller LC, Jaroszeski MJ, Coppola D., McCray AN, Hickey J., Heller R. Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther. 2007 ; 14: 275-280.
109. Prat V. Drug and gene delivery using electrotransfer. Ann Pharm Fr. 2001 ; 59: 239-244.
110. Chesnoy S., Huang L. Enhanced cutaneous gene delivery following intradermal injection of naked DNA in a high ionic strength solution. Mol Ther. 2002 ; 5: 57-62.
111. Ferguson M., Byrnes C., Sun L., et al. Wound healing enhancement: electroporation to address a classic problem of military medicine. World J Surg. 2005 ; 29: S55 - S59.
112. Pliquett U., Weaver JC Feasibility of an electrode-reservoir device for transdermal drug delivery by noninvasive skin electroporation. IEEE Trans Biomed Eng. 2007 ; 54: 536-538.
113. Burgess SE, Zhao YL, Sen A., Hui SW Resealing of electroporation of porcine epidermis using phospholipids and poloxamers. Int J Pharm. 2007 ; 336: 269-275.
114. Chen T., Langer R., Weaver JC Skin electroporation causes molecular transport across the stratum corneum through localized transport regions. J Investig Dermatol Symp Proc. 1998 ; 3: 159-165.